Tourmaline Bio Inc.
(TRML)
undefined
undefined%
At close: undefined
21.81
-0.37%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | 33.00K | 6.00K | 623.00K | 447.00K | 379.00K |
Gross Profit | -33.00K | -6.00K | -623.00K | -447.00K | -379.00K |
Operating Income | -45.41M | -19.70M | -904 | -22.68M | -18.38M |
Interest Income | - | - | - | - | 223.00K |
Pretax Income | -42.12M | -19.70M | -904 | -22.71M | -18.16M |
Net Income | -42.12M | -19.70M | -904 | -22.71M | -18.16M |
Selling & General & Admin | 13.04M | 2.17M | 692.00 | 6.96M | 4.63M |
Research & Development | 32.37M | 17.53M | 212.00 | 15.28M | 13.37M |
Other Expenses | - | - | - | - | - |
Operating Expenses | 45.41M | 19.70M | 904.00 | 22.24M | 18.00M |
Interest Expense | - | - | - | 23.00K | - |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 45.41M | 19.70M | 904.00 | 22.68M | 18.38M |
Income Tax | - | - | -47.21M | - | - |
Shares Outstanding (Basic) | 4.75M | 20.34M | 10.88M | 668.51K | 4.13M |
Shares Outstanding (Diluted) | 4.75M | 20.34M | 10.88M | 668.51K | 4.13M |
EPS (Basic) | -8.87 | -0.97 | -0.00 | -33.97 | -4.39 |
EPS (Diluted) | -8.87 | -0.97 | -0.00 | -33.97 | -4.39 |
EBITDA | -45.38M | -19.70M | -46.88M | -22.24M | -17.78M |
Depreciation & Amortization | 33.00K | 6.00K | 904.00 | 447.00K | 379.00K |